Published in Ann Rheum Dis on August 01, 1995
Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta (1986) 13.69
Matrix metalloproteinases: a review. Crit Rev Oral Biol Med (1993) 9.03
A rapid and reproducible assay for collagenase using [1-14C]acetylated collagen. Anal Biochem (1979) 3.17
Long-term outcome of treating rheumatoid arthritis: results after 20 years. Lancet (1987) 2.81
Cathepsin B1. A lysosomal enzyme that degrades native collagen. Biochem J (1974) 2.65
Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J Clin Invest (1989) 2.33
Gene expression (collagenase, tissue inhibitor of metalloproteinases, complement, and HLA-DR) in rheumatoid arthritis and osteoarthritis synovium. Quantitative analysis and effect of intraarticular corticosteroids. Arthritis Rheum (1991) 2.28
Histopathology of the rheumatoid lesion. Identification of cell types at sites of cartilage erosion. Arthritis Rheum (1984) 1.85
Three-dimensional collagen architecture in bovine articular cartilage. J Bone Joint Surg Br (1991) 1.80
Expression of metalloproteinases and metalloproteinase inhibitor in human arthritic synovium. Arthritis Rheum (1991) 1.73
Direct evidence for active metalloproteinases mediating matrix degradation in interleukin 1-stimulated human articular cartilage. Matrix (1993) 1.42
Inhibition of cartilage proteoglycan release by a specific inactivator of cathepsin B and an inhibitor of matrix metalloproteinases. Evidence for two converging pathways of chondrocyte-mediated proteoglycan degradation. Arthritis Rheum (1993) 1.30
The prevention of collagen breakdown in bovine nasal cartilage by TIMP, TIMP-2 and a low molecular weight synthetic inhibitor. Biochem Biophys Res Commun (1994) 1.10
Studies into the influence of carrageenan-induced inflammation on articular cartilage degradation using implantation into air pouches. Br J Exp Pathol (1985) 1.10
Studies on the mechanism of cartilage degradation. J Pathol (1984) 1.07
Inhibition of interleukin 1-stimulated cartilage proteoglycan degradation by a lipophilic inactivator of cysteine endopeptidases. Biochem J (1992) 0.99
Effect of synthetic metalloprotease inhibitors on cartilage autolysis in vitro. J Pharmacol Exp Ther (1987) 0.96
A synthetic peptide metalloproteinase inhibitor, but not TIMP, prevents the breakdown of proteoglycan within articular cartilage in vitro. Agents Actions (1992) 0.94
A review of the histopathological evidence on the pathogenesis of cartilage destruction in rheumatoid arthritis. Scand J Rheumatol Suppl (1988) 0.88
Lysosomal cysteine endopeptidases mediate interleukin 1-stimulated cartilage proteoglycan degradation. Biochem J (1992) 0.87
The production in culture of metalloproteinases and an inhibitor by joint tissues from normal rabbits, and from rabbits with a model arthritis. II. Articular cartilage. Rheumatol Int (1981) 0.86
Synthesis of novel modified dipeptide inhibitors of human collagenase: beta-mercapto carboxylic acid derivatives. J Med Chem (1993) 0.86
A modified mouse air pouch model for evaluating the effects of compounds on granuloma induced cartilage degradation. Br J Pharmacol (1988) 0.84
Experimental animal models resembling rheumatoid arthritis. Clin Rheumatol (1992) 0.83
Cartilage damage by a granulomatous reaction in a murine species. Br J Exp Pathol (1987) 0.83
A simple in vivo model of collagen degradation using collagen-gelled cotton buds: the effects of collagenase inhibitors and other agents. Inflamm Res (1995) 0.83
A novel in vivo model for the study of cartilage degradation. J Pharmacol Toxicol Methods (1993) 0.80
Ultrastructure and X-ray microanalysis of epiphyseal growth cartilage of femoral head processed by rapid-freezing and freeze-substitution. Acta Med Okayama (1993) 0.78
Inhibition of fibril formation in beta-amyloid peptide by a novel series of benzofurans. Biochem J (1999) 8.68
Progress in spinal cord research - a refined strategy for the International Spinal Research Trust. Spinal Cord (2000) 1.16
Target cells, biological effects, and mechanism of action of nerve growth factor and its antibodies. Annu Rev Pharmacol Toxicol (1981) 1.10
Ernest (Che) Guevara. Physician--revolutionary physician--revolutionary. N Engl J Med (1969) 1.04
The production of nerve growth factor in vitro by tissues of the mouse, rat, and embryonic chick. Dev Biol (1980) 1.03
The purification of nerve growth factor from bovine seminal plasma. Biochemical characterization and partial amino acid sequence. J Biol Chem (1982) 1.02
Common structural features determine the effectiveness of carvedilol, daunomycin and rolitetracycline as inhibitors of Alzheimer beta-amyloid fibril formation. Biochem J (1999) 0.97
Obesity, sodium intake, and blood pressure in adolescents. Hypertension (1980) 0.97
Synthesis of novel N-phosphonoalkyl dipeptide inhibitors of human collagenase. J Med Chem (1994) 0.96
Height and perceived competence of US presidents. Percept Mot Skills (1996) 0.96
A synthetic peptide metalloproteinase inhibitor, but not TIMP, prevents the breakdown of proteoglycan within articular cartilage in vitro. Agents Actions (1992) 0.94
IgE secretion is attenuated by an inhibitor of proteolytic processing of CD23 (Fc epsilonRII). Eur J Immunol (1997) 0.94
Production of nerve growth factor by the mouse adrenal medulla. Nature (1976) 0.92
Nerve growth factor: biological significance, measurement, and distribution. J Neurochem (1980) 0.89
Amitriptyline in the treatment of anorexia nervosa: a double-blind, placebo-controlled study. J Clin Psychopharmacol (1985) 0.89
The distribution of nerve growth factor in the male sex organs of mammals. J Neurochem (1980) 0.88
Guinea pig prostate is a rich source of nerve growth factor. Nature (1979) 0.88
Biological and immunological properties of the nerve growth factor from bovine seminal plasma: comparison with the properties of mouse nerve growth factor. Neuroscience (1983) 0.87
Antifungal activity of selective serotonin reuptake inhibitors attributed to non-specific cytotoxicity. J Antimicrob Chemother (2003) 0.86
Synthesis of novel modified dipeptide inhibitors of human collagenase: beta-mercapto carboxylic acid derivatives. J Med Chem (1993) 0.86
Alzheimer's disease: correlation of the suppression of beta-amyloid peptide secretion from cultured cells with inhibition of the chymotrypsin-like activity of the proteasome. J Neurochem (1999) 0.85
Crystallization and preliminary X-ray analysis of porcine synovial collagenase. J Mol Biol (1989) 0.83
A simple in vivo model of collagen degradation using collagen-gelled cotton buds: the effects of collagenase inhibitors and other agents. Inflamm Res (1995) 0.83
The production and storage of nerve growth factor in vivo by tissues of the mouse, rat, guinea pig, hamster, and gerbil. Dev Biol (1980) 0.81
Inhibition of arachidonic acid-induced ear oedema as a model for assessing topical anti-inflammatory compounds. Agents Actions (1987) 0.81
High-resolution magnetic resonance imaging of arthritic pathology in the rat knee. Skeletal Radiol (1994) 0.81
Locus of control, depression, and anger among African-Americans. Psychol Rep (1993) 0.78
Inhalant use among American Indian youth. Child Psychiatry Hum Dev (1987) 0.77
Xylose malabsorption and growth retardation in East Pakistani children. Am J Clin Nutr (1972) 0.76
Nucleotide sequence of a cDNA for porcine type I collagenase, obtained by PCR. Nucleic Acids Res (1990) 0.75
Hitler's psychopathology: advantages and limitations of psychohistorical assessments of personality. Psychol Rep (1996) 0.75
Urinary mhpg in anorexia nervosa patients with and without a concomitant major depressive disorder. J Psychiatr Res (1984) 0.75
An in vivo model of collagen degradation. Matrix Suppl (1992) 0.75
Platelet MAO activity in anorexia nervosa patients with and without a major depressive disorder. Am J Psychiatry (1984) 0.75
Antihypertensive and angiotensin converting enzyme inhibitory activities of a novel dihydrobenzofuran analogue. Arzneimittelforschung (1988) 0.75
Visualisation of subchondral erosion in rat monoarticular arthritis by magnetic resonance imaging. Skeletal Radiol (1995) 0.75
Azabicyclic indole esters as potent 5-HT4 receptor antagonists. Bioorg Med Chem (1996) 0.75
Anorexia nervosa and affective disorders: a controlled family history study. Am J Psychiatry (1984) 0.75
Purification and secondary structural analysis of tissue inhibitor of metalloproteinases-1. Biochim Biophys Acta (1994) 0.75
Letter: Fluorination of saturated carbon. 2. Direct fluorination of steroids. J Am Chem Soc (1976) 0.75
7-Aroyl-2,3-dihydrobenzo[b]furan-3-carboxylic acids and 7-benzoyl-2,3-dihydrobenzo[b]thiophene-3-carboxylic acids as analgesic agents. J Med Chem (1986) 0.75
Sensation seeking and self-reported criminality among student-athletes. Percept Mot Skills (1990) 0.75
Alienation and self-reported deviance. Psychol Rep (1989) 0.75
Novel 1H-benzimidazol-4-ols with potent 5-lipoxygenase inhibitory activity. J Med Chem (1987) 0.75
Felonious murder of police officers by ambush. Psychol Rep (1990) 0.75
Who are our assaultive juveniles? A study of 100 cases. J Forensic Sci (1973) 0.75
Personality assessment in equivocal deaths. J Pers Assess (1992) 0.75
Angiogenesis and chronic inflammation. Meeting of the British Inflammation Research Association (BIRAs) 5th June, 1990. Roche Products, Welwyn Garden City. Agents Actions (1991) 0.75
Collagen degradation within subcutaneous air pouches in vivo: the effects of proteinase inhibitors. J Pharmacol Toxicol Methods (1995) 0.75
Management of cutaneous atrophy after corticosteroid injection. J Am Acad Dermatol (1987) 0.75
Endocrinologic and psychological effects of short-term dexamethasone in anorexia nervosa. Eat Weight Disord (2000) 0.75
Cloning of a cDNA for porcine type I collagenase and expression in E. coli. Biochem Soc Trans (1991) 0.75